Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia

Thorax

Volumn 53, Issue 5, 1998, Pages 432-436

  Ledson, M J ^a   Gallagher, M J ^a   Corkill, J E ^a   Hart, C A ^a   Walshaw, M J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Burkholderia cepacia; Cross infection; Cystic fibrosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HUMAN; INFECTION PREVENTION; MALE; PATIENT CARE; PRIORITY JOURNAL;

EID: 0031866071     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.5.432     Document Type: Article

References (24)

1. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Paediatr 1984;104:206-10.
2. Govan JRW, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
3. Smith DL, Gumery LB, Smith EG, et al. Evidence of Pseudomons cepacia transmission in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993;31:3017-22.
4. Newsletter of the Association of Cystic Fibrosis Adults (UK). Cystic Fibrosis statement on Pseudomonas cepacia. 1993;37:2-5.
5. + Burkholderia cepacia causing cystic fibrosis centre epidemics in North America and Britain. Nature Medicine 1995;1;661-6.
6. Pitt TL, Kaufmann ME, Patel PS, et al. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996;44:203-10.
7. De Lamballerie X, Zandotti C, Vignloli C, et al. A one step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res Microbiol 1992;143: 785-90.
8. Dasen SE, LiPuma JJ, Kostman JR, et al. Characterisation of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol 1994;32:2422-4.
9. Sajjan US, Sun L, Goldstein R, et al. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibres. J Bacteriol 1995;177:1030-8.
10. Fitzsimmons S. United States Cystic Fibrosis Foundation. Unpublished analysis, 1996.
11. Johnson WM, Tyler SD, Rozee KR. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994;32:924-30.
12. Nelson JW, Doherty CJ, Brown PH, et al. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 1991;338:1525 (letter).
13. Thomassen MJ, Demko CA, Klinger JD, et al. Pseudomonas cepacia colonisation among patients with cystic fibrosis: a new opportunist. Am Rev Respir Dis 1985;131:791-6.
14. Burdge DR, Nakielna EM, Noble MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Epidemiol 1993;14:127-30.
15. Hutchinson GR, Parker S, Pryor JA, et al. Home-use nebulisers: a potential primary source of Burkholderia cepacia and other colistin-resistant, Gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996;34:584-7.
16. Humphreys H, Peckham D, Patel P, et al. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax 1994;49:456-9.
17. Larsen GY, Stull TL, Burns JL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol 1993;31:788-92.
18. Kostman JR, Edlind TD, LiPuma JJ, et al. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol 1992;30:2084-7.
19. Ryley HC, Millar-Jones L, Paull A, et al. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. J Med Microbiol 1995;43:436-41.
20. Anderson DJ, Kuhns JS, Vasil ML, et al. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia from a nosocomial outbreak. J Clin Microbiol 1991;29:648-9.
21. Sun L, Jiang R-Z, Agodi A, et al. PFGE versus ribo-, pil- and tox-typing for detection of persistence, clonality of infection and cross-spread by cystic fibrosis-associated Ps aeruginosa. Pediatr Pulmonol 1992;S8:A195.
22. Goldstein R, Sun L, Jiang R-Z, et al. Structurally variant classes of pilus appendage fibres coexpressed from Burkholderia cepacia. J Bacteriol 1992;177:1039-55.
23. Tyler SD, Rozee KR, Johnson WM. Identification of IS1356, a new insertion sequene, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol 1996;34:1610-6.
24. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterisation of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-16.